Webinars

Despite all of their promise, newer medicines, especially those based on advanced technologies, have been met with unprecedented challenges in scaling up manufacturing, quality control and commercial launch. Hear how developers have approached different aspects of the manufacturing process to bring new and innovative treatments to patients.

On Aug 7th, 2022, the US House of representatives passed a bill on budget reconciliation which included a section on US Drug pricing reform (Part B). The reform requires federal government to negotiate drug prices under Medicare to ensure significant discounts on branded therapies and eliminate annual price increases. The bill further requires pharmaceutical companies to pay rebates if drug prices rise faster than inflation for Medicare and private insurances.

Join Precision ADVANCE and Endpoints News as we kick off Cell & Gene Day, where we'll convene three expert panels to find out where the field stands today and explore funding, development and launch strategies to smooth out the ride to commercialization.

Lab of the future requires a modern, connected, adaptable solution that manages work traditionally done in siloed – and now outdated – ELN and LIMS solutions. With a shared solution connecting R&D data, teams can manage samples and processes with seamless handoffs and complete traceability. Join us for an engaging discussion with Dan Chapman, Director of the Experiment Design and Execution Platform Product at Merck, and experts from Zifo and Benchling.

Join Dr. Greg Johnson, CEO of Hospital Medicine and Chief Diversity Officer at Sound Physicians, for an engaging discussion where he will share how to confront these care gaps and advance health equity in hospital medicine.

This solution-focused, truth-packed session is a great fit for market access marketers, brand marketers and sales leaders who are interested in making their brands’ market access a top advantage over the competition.

Join your peers to learn how pharmaceutical and life sciences organizations use conversational AI to automate workflows and communication to increase efficiency and reduce costs. Panelists from Pfizer and other leaders in the industry will discuss how artificial intelligence impacts and improves pharma's relationships with physicians, consumers, insurers, and regulators. You will gain insights into how mobile apps can streamline the treatment journey and the power of automated communication to improve awareness, access, and adherence. Finally, you'll also walk away with real-life examples of how physicians harness innovation and digital tactics for new patient acquisition and patient support. Come prepared with questions so you can drive superior results for your organization.

Data standardization is across medical device types and manufactures is exceedingly uncommon and acts as a barrier to capturing and integrating data to improve quality of care. Baylor, Scott, and White Health tackled this problem by bringing together an interdisciplinary group of staff and implementing a scalable system enterprise-wide. Join Lisa Kilgore and Nathan Winn from Baylor and Scott in a webinar this Monday, July 25th, to learn more.

Once again Congress is barreling towards drug pricing reform. STAT will sit down with key decision makers to talk about the latest developments from Capitol Hill and the White House.

Artificial intelligence could play a role in the future of patient care — managing everything from office visits to surgery and radiology. A look at how researchers aim to create a "data economy" to ensure that these new technologies live up to their potential.

Some security firms have warned that biopharma companies are increasingly being targeted for cyberattacks (Merck is still dealing with the aftermath of the 2017 attack). How vulnerable are drug developers, what’s at stake and what steps can be taken to prevent a devastating attack? And what are the best strategies for both big and small organizations?

In this webinar, experts will share insights into intranasal vaccine formulation development and discuss the current state of the art in intranasal vaccine production from development to commercial scale. In addition, a detailed discussion on the challenges and opportunities of intranasal approaches will be presented including the importance of device selection in determining product performance.

Join Dr. Jessica Paulus as she explores opportunities and challenges with using RWD in conducting CER.

In this webinar, you will learn what surveyed healthcare decision-makers from 56 payer organizations and 45 institutions' preferences are related to meetings and gathering product information and hear live payer perspectives of these results from a former medical director and pharmacy director. Earlene Biggs, MA, VP of Market Research and Analytics at ICON Market Access and Reimbursement will share findings of the survey alongside payer experts, Gary Owens, MD, former VP of Medical Management and Policy and Renee Fleming, RPh, MBA, former VP of Pharmacy Services, both having 20+ years of health plan experience in medical and pharmacy management.

This webinar will demonstrate several technology and data-enabled approaches to capturing relevant data in parallel with clinical development to set up Market Access teams for success as early as possible.

Join us as we address the intersection of LGBTQ+ and Parkinson's disease communities. We will hear from members of the LGBTQ+ community who are living with Parkinson’s disease, specifically as it relates to identity, access to care, and finding community support and resources. Together, we will explore ways to improve Parkinson’s healthcare and delivery to LGBTQ+ patients and decrease health disparities, while promoting cultural competencies and cultural humility among healthcare providers. We will explore Parkinson’s medications and therapies and their impact on the LGBTQ+ community.

The clinical trials industry has experienced rapid change as a result of decentralization and digitalization, prompting more questions from sponsors and clinical research organizations about current remote study operations best practices.

Digital transformation doesn’t need to happen overnight, especially when staff are already overwhelmed with competing priorities, COVID-19 surges, and complex care demands. To address communication issues, Newark Beth Israel Medical Center found that expanding on small tests of change was an effective way to facilitate sustainable improvement.

Digital health has transformed many parts of the healthcare industry and improved upon the patient experience. But is there room in digital health for caregivers? How are new technology advancements helping to support the role of caregivers in the patient journey? And what are the unique challenges that caregivers face that may be different from the patient themselves?

Even during COVID-19, U.S. Food and Drug Administration (FDA) inspections carried on. However, quality assurance inspections weren't the only way the FDA ensured quality. The agency used a number of remote tools to interact with pharmaceutical and medical device companies before performing an inspection or deciding it could wait. Join us for a webinar discussing these tools and how the FDA has changed its processes.